tradingkey.logo
tradingkey.logo
Buscar

Basel Medical Group Ltd

BMGL
Añadir a la lista de seguimiento
0.656USD
-0.044-6.26%
Cierre 05/15, 16:00ETCotizaciones retrasadas 15 min
12.33MCap. mercado
PérdidaP/E TTM

Basel Medical Group Ltd

0.656
-0.044-6.26%

Más Datos de Basel Medical Group Ltd Compañía

Basel Medical Group Ltd is a holding company, which operates through its subsidiary, Basel Medical Group Pte. Ltd. It provides a wide spectrum of general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. Its orthopedic treatments and surgery include non-surgical treatments, such as medications, injections, splinting and physiotherapy, and surgical orthopedic procedures, including minimally invasive treatments for complex surgeries. Its rehabilitative therapy provides in-house physiotherapy treatments, including post-surgery rehabilitation, as well as sports therapy. Its neurosurgical care covers treatments involving spinal and brain conditions, from headaches and brain tumors to spinal issues, aneurysms and strokes. It also specializes in diagnostic imaging and outpatient care.

Información de Basel Medical Group Ltd

Símbolo de cotizaciónBMGL
Nombre de la empresaBasel Medical Group Ltd
Fecha de salida a bolsaFeb 25, 2025
Director ejecutivoChhoa (Yen Feng)
Número de empleados77
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 25
Dirección600 North Bridge Road, #12-02/03
Ciudad
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísSingapore
Código postal188778
Teléfono6562919188
Sitio Webhttps://www.baselmedical.com
Símbolo de cotizaciónBMGL
Fecha de salida a bolsaFeb 25, 2025
Director ejecutivoChhoa (Yen Feng)

Ejecutivos de Basel Medical Group Ltd

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Jianing Lu
Ms. Jianing Lu
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Dr. Yen Feng (Darren) Chhoa, M.D.
Dr. Yen Feng (Darren) Chhoa, M.D.
Chief Executive Officer
Chief Executive Officer
--
--
Mr. Paul D. Freudenthaler, CPA
Mr. Paul D. Freudenthaler, CPA
Independent Director
Independent Director
--
--
Mr. Tony Chen
Mr. Tony Chen
Independent Director
Independent Director
--
--
Mr. Kwek Yoon Soong
Mr. Kwek Yoon Soong
Independent Director
Independent Director
--
--
Mr. Boon Chye Tan
Mr. Boon Chye Tan
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Keng Leong (Raymond) Fung
Mr. Keng Leong (Raymond) Fung
Chairman of the Board
Chairman of the Board
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Jianing Lu
Ms. Jianing Lu
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Dr. Yen Feng (Darren) Chhoa, M.D.
Dr. Yen Feng (Darren) Chhoa, M.D.
Chief Executive Officer
Chief Executive Officer
--
--
Mr. Paul D. Freudenthaler, CPA
Mr. Paul D. Freudenthaler, CPA
Independent Director
Independent Director
--
--
Mr. Tony Chen
Mr. Tony Chen
Independent Director
Independent Director
--
--
Mr. Kwek Yoon Soong
Mr. Kwek Yoon Soong
Independent Director
Independent Director
--
--
Mr. Boon Chye Tan
Mr. Boon Chye Tan
Chief Commercial Officer
Chief Commercial Officer
--
--

Desglose de ingresos

La empresa aún no ha revelado los datos relevantes.
La empresa aún no ha revelado los datos relevantes.
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.

Estadísticas de accionistas

Actualizado: sáb., 9 de may
Actualizado: sáb., 9 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Rainforest Capital VCC
54.32%
XTX Markets LLC
0.16%
Citadel Advisors LLC
0.13%
Susquehanna International Group, LLP
0.08%
T3 Companies, LLC
0.08%
Otro
45.22%
Accionistas
Accionistas
Proporción
Rainforest Capital VCC
54.32%
XTX Markets LLC
0.16%
Citadel Advisors LLC
0.13%
Susquehanna International Group, LLP
0.08%
T3 Companies, LLC
0.08%
Otro
45.22%
Tipos de accionistas
Accionistas
Proporción
Corporation
54.32%
Hedge Fund
0.21%
Investment Advisor
0.20%
Venture Capital
0.16%
Research Firm
0.09%
Investment Advisor/Hedge Fund
0.04%
Bank and Trust
0.03%
Otro
44.95%

Participación institucional

Actualizado: mié., 1 de abr
Actualizado: mié., 1 de abr
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2026Q1
22
136.26K
0.73%
-284.73K
2025Q4
14
296.50K
0.70%
--
2025Q3
14
296.50K
0.70%
+165.18K
2025Q2
6
124.34K
0.00%
+124.34K
2025Q1
5
12.74M
67.81%
+12.74M

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Rainforest Capital VCC
10.21M
54.32%
+30.65K
+0.30%
Nov 17, 2025
XTX Markets LLC
30.43K
0.16%
+30.43K
--
Dec 31, 2025
Citadel Advisors LLC
24.67K
0.13%
-68.33K
-73.47%
Dec 31, 2025
Susquehanna International Group, LLP
15.29K
0.08%
+15.29K
--
Dec 31, 2025
Renaissance Technologies LLC
14.50K
0.08%
+14.50K
--
Dec 31, 2025
Geode Capital Management, L.L.C.
6.97K
0.04%
--
--
Jan 31, 2026
UBS Financial Services, Inc.
8.09K
0.04%
+2.19K
+37.12%
Dec 31, 2025
Coston, McIsaac & Shea Financial Advisors
50.00
0%
--
--
Dec 31, 2025
Ver más

ETFs relacionados

Nombre
Proporción
Sin datos

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI